From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

Cash Burn -- $50.2 million in 2025, an improvement from $57.8 million in 2024 due to lower headcount and development costs.

Explore the new AI foundation model by Insilico Medicine and Liquid AI for efficient pharmaceutical research on private ...

Adults whose brains still have strong neuron production seem to have better memory and cognitive function than do those in whom the ability wanes, finds a study published today in Nature. The authors ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...

Study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...

Ultrasound-mediated nanobubbles improve cancer therapy by softening tumors, enhancing lipid nanoparticle distribution, and ...

Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure CAMBRIDGE, Mass., March 3, 2026 ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering single-molecule proteome analysis, today announced the appointment of Amber Faust as Vice President of Sales. Ms. Faust joins Nautilus ...